Finally, the identification of single nucleotide polymorphism of IL-22 binding protein (IL-22BP, also called IL-2RA), an antagonist of IL-22, as an MS risk gene [138,139] supports a role of IL-22-producing cells in the immunopathogenesis of MS. This evidence concerns the gene IL22 and myeloid sarcoma.